HSBC says stock markets are pricing in a recession, not stagflation. Here's how it’s trading the rotation

HSBC strategists say the likelihood of looming stagflation "has barely moved" while equity markets appear to be pricing in a recession, highlighting a divergence in macro pricing. The note identifies potential buying opportunities in specific countries and sectors, with emerging markets and cyclical stocks singled out. Positioning implication: remain cautious on broad equity exposure given recession pricing, but consider tactical allocations to EM and selected cyclicals.

Analysis

Markets currently embed a deeper recession than macro fundamentals justify — that dislocation creates asymmetric upside in cyclicals and EM once growth stabilizes. Mechanically, a 3–5% USD decline or a 50–75bp drop in 2y UST yields (both realistic within 3–9 months if CPI momentum eases) historically correlates with 10–20% outperformance of EM equities and industrials versus US defensives.

Winners on the rerating path are EM commodity exporters and banks: commodity export receipts improve sovereign/corporate balance sheets and EM bank NIMs widen as local rates normalize, creating a levered earnings catch-up over 6–12 months. Second-order beneficiaries include shipping/containers and industrial capital goods OEMs as restocking lifts volumes; losers are long-duration growth and EM import-dependent consumer plays where margin compression and FX weakness erode earnings.

Key risks are a durable stagflation regime or a renewed Fed tightening cycle — if core CPI re-accelerates such that 2y UST yields rise >75bp or USD strengthens >5% within 60 days, cyclical/EM exposure can see 15–30% drawdowns. Watch short-term signals (next 1–3 CPI prints, China PMI, US payrolls) as catalysts for fast repricing, while the 3–9 month window is the most probable horizon for a mean reversion trade to pay off.

Consensus is too binary: pricing assumes an imminent hard landing, but policy and fiscal buffers leave a greater probability of shallow or rolling slowdown. That makes a patient, option-aware scaling into EM/cyclical long exposure attractive — starter positions now (25–75bp) with convex adds on meaningful pullbacks (EM -10% or VIX >20) offer favorable asymmetric payoffs.

Key Decisions for Investors

• Pair trade (6–12 months): Long EEM 1.0% NAV vs Short IVV 0.6% NAV (net beta ~0.4). Rationale: capture EM re-rating if USD weakens; target 15–20% relative return, stop if the pair underperforms by 8% (cut losses).
• Sector pair (3–6 months): Long XLI 0.6% NAV / Short XLP 0.6% NAV. Use 1–2x notional in industrials vs staples to exploit cyclical recovery; target 12–18% gross on the long leg, stop the pair at a 10% adverse move or if 2y UST rises >50bp in 10 trading days.
• Selective commodity/EM names (3–9 months): Long VALE 0.3% NAV and BHP 0.3% NAV, or buy VALE/BHP 3–6 month call spreads (buy ATM, sell 15–20% OTM) to cap cost. Expect 20–30% upside if Chinese demand stabilizes; downside 15–25% in a hard-landing scenario—use tight stops or option structures.
• Convex hedge and inflation hedge (1–3 months): Buy SPX 3-month 2% OTM puts sized to protect 1% of portfolio notional OR allocate 0.5% NAV to TIP (TIPS ETF) as an insurance against stagflation. These reduce tail risk while keeping directional exposure intact.